Partnerships

Roche and UC San Diego have established UC San Diego-Roche Extending Innovation Network (EIN) program. The program aims to accelerate drug discovery development through joint collaboration and...

Novo Nordisk and Kennedy Institute of Rheumatology at Oxford University have entered into partnership to develop new drugs to treat Rheumatoid Arthritis and other inflammatory disorders. Novo...

JDRF and Novo Nordisk have entered into collaboration to develop new immunotherapies to treat Type 1 diabetes. The new partnership will be based out of Novo's newly opened Type 1 Diabetes R&D...

UCB has entered into a research and development partnership with Oxford University in Neurology and Immunology areas. UCB will provide 3.6 million pounds to Oxford scientists over a period of three...

Johnson & Johnson and Institute for Molecular Bioscience (IMB) at University of Queensland have entered into research agreement to develop peptides using IMB's novel assay to treat chronic...

University of Cambridge and Elan jointly established Cambridge - Elan Centre for Research Innovation and Drug Discovery. The new center will be based out of Cambridge and will focus primarily in...

Vanderbilt University and GSK have entered into partnership to develop drugs to treat Obesity. GSK will provide funding support to Vanderbilt for three years.

Merck Pharmaceuticals has committed to fund $90 million over period of seven years to establish California Institute for Biomedical Research (Calibr) in San Diego, California. The new center will...

A consortium of academic institutes from Germany, Britain, Netherlands and Denmark partner with a group of leading pharmaceutical companies which include AstraZeneca, Sanofi, Bayer, UCB , ,...

University of California, San Francisco (UCSF) and Genetech have entered into a research collaboration to develop drugs to treat neurodegenerative diseases. Genetech will be providing funding to...